enow.com Web Search

  1. Ads

    related to: is airsculpt fda approved for prostate cancer
    • Patient Resources

      Download informative brochures for

      patients and caregivers.

    • About Us

      Understand how a PSMA PET scan may

      help with your treatment plan.

Search results

  1. Results from the WOW.Com Content Network
  2. Padeliporfin - Wikipedia

    en.wikipedia.org/wiki/Padeliporfin

    Padeliporfin, sold under the brand name Tookad, is a medication used to treat men with prostate cancer. [1] [2] It is used in the form padeliporfin di-potassium.[2]The most common side effects include problems with urinating (pain, inability to pass urine, strong urge to pass urine, frequent urination, and incontinence), sexual problems (erectile dysfunction and ejaculation failure), blood in ...

  3. List of unproven and disproven cancer treatments - Wikipedia

    en.wikipedia.org/wiki/List_of_unproven_and...

    The U.S. National Cancer Institute notes "Cannabis is not approved by the FDA for the treatment of any cancer-related symptom or side effect of cancer therapy." [61] Cansema (also called black salve) – a type of paste or poultice often promoted as a cancer cure, especially for skin cancer.

  4. Gallium (68Ga) gozetotide - Wikipedia

    en.wikipedia.org/wiki/Gallium_(68Ga)_gozetotide

    Gallium (68Ga) gozetotide was approved for medical use in the United States in December 2021, [13] [14] and in the European Union in December 2022. [10] It is the first drug approved by the US Food and Drug Administration (FDA) as a PET imaging agent. [12]

  5. AstraZeneca-Merck Lynparza Prostate Cancer Treatment Gets FDA ...

    www.aol.com/news/astrazeneca-merck-lynparza...

    AstraZeneca Plc’s (AZN) and Merck Co.’s (MRK) Lynparza drug has received a green light from the U.S. Food and Drug Administration (FDA) for the treatment of patients with advanced prostate ...

  6. Proxalutamide - Wikipedia

    en.wikipedia.org/wiki/Proxalutamide

    Proxalutamide (developmental code name GT-0918) is a nonsteroidal antiandrogen (NSAA) – specifically, a selective high-affinity silent antagonist of the androgen receptor (AR) – which is under development by Suzhou Kintor Pharmaceuticals, inc., a subsidiary of Kintor Pharmaceutical Limited, for the potential treatment of COVID-19, prostate cancer, and breast cancer.

  7. J&J's Prostate Cancer Drug Zytiga Approved for Earlier ... - AOL

    www.aol.com/2013/01/11/jjs-prostate-cancer-drug...

    On Friday, Johnson & Johnson's Zytiga received an expanded approval from the European Commission. The drug was previously approved for patients with metastatic castration-resistant prostate cancer ...

  1. Ads

    related to: is airsculpt fda approved for prostate cancer